An inhaled form of insulin called Oralin, taken at meal time, appears to control glucose and insulin levels as effectively as subcutaneously injected insulin in type I diabetics, according to new research The RapidMist inhaler is used to deliver the Oralin liquid aerosol formulation, allowing a precise insulin dose directly the mouth.
According to Dr. Pankaj Modi, Director of Research and Development at Generex, the biggest challenge in the development of inhaled insulin has been to overcome the problem of gastric enzymes, which can make absorption erratic.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!